Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Alliance Pharma ( (GB:APH) ).
Alliance Pharma PLC has announced an adjournment of its Court and General Meetings regarding the acquisition by Aegros Bidco Limited, a company indirectly owned by DBAY Affiliates and the ERES IV Fund. This delay is intended to provide more time for discussions with shareholders and for them to consider the acquisition terms. The meetings are rescheduled for March 13, 2025, and this move indicates the company’s effort to ensure shareholder alignment and transparency in the acquisition process.
More about Alliance Pharma
YTD Price Performance: 36.61%
Average Trading Volume: 4,610,632
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £337.9M
For an in-depth examination of APH stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue